Skip to main content
. 2021 Nov 16;13(11):1940. doi: 10.3390/pharmaceutics13111940

Figure 9.

Figure 9

Hemoglobin release from human red blood cells (RBCs) incubated in the presence of CSA-13; AuR-NPs, AuP-NPs, and AuS-NPs containing CSA-13 (AC); CSA-44; AuR-NPs, AuP-NPs, and AuS-NPs containing CSA-44 (DF); and CSA-131; AuR-NPs, AuP-NPs, and AuS-NPs containing CSA-131 (GI) at doses of 1–50 μg/mL after 1 h (A,D,G), 6 h (B,E,H), and 12 h (C,F,I) of incubation. Results show the mean ± SD, n = 3; * indicates statistical significance at ≤0.05, ** ≤0.01, and *** ≤0.001.